Santhera Pharmaceuticals Holding AG (S3F0)
Market Closed
15 Jun, 20:00
€
16. 90
+0.04
+0.2372%
€
- Market Cap
- P/E Ratio
- Div Yield
0 Volume
-6.11 Eps
€ 16.86
Previous Close Want to track S3F0 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Santhera Pharmaceuticals Holding AG (S3F0) Statistics
Valuation metrics
Market Cap -
Enterprise value 26.51M
Trailing P/E (ttm) -4.79
Forward P/E -
PEG ratio -
Price/Sales (ttm) -
Price/Book (mrq) -
Enterprise Value/Revenue 0.34
Enterprise Value/EBITDA -0.76
Overview
Shares outstanding 13.39M
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 54
Average volume (90 days) 18
Price summary
52-Week low 10.14
52-Week high 20.2
Beta -
50-Day moving average 17.93
200-Day moving average 14.76
Dividends and splits
Forward annual dividend rate -
Forward annual dividend yield -
Trailing annual dividend rate -
Trailing annual dividend yield -
5-Year annual dividend yield -
Payout ratio -
Dividend Date -
Ex-Dividend Date -
Last split factor 1:10
Last split Date 3 Jul 2023
Financials
Fiscal year
Fiscal year ends 31 Dec 2025
Most recent quarter (mrq) 31 Dec 2025
Profitability
Profit margin 0.2%
Operating margin -0.49%
Operational effectiveness
Return on assets -0.33%
Return on equity 4.17%
Income Statement
Revenue (ttm) 77.19M
Revenue per share (ttm) 5.93
Quarterly revenue growth (yoy) -
Gross profit (ttm) 15.17M
EBITDA -
Net income to common (ttm) -49.24M
Diluted EPS (ttm) -3.78
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) 22.44M
Total cash per share (mrq) -
Total debt (mrq) 48.95M
Total Debt/Equity (mrq) -4.14
Current ratio (mrq) 1.29%
Book value per share (mrq) -
Cash Flow
Cash flow statement -34.91M
Levered free cash flow (LFCF) -49.24M
